DK312386D0 - N-aralkyl-piperidenmethanolderivater samt disses fremstilling - Google Patents

N-aralkyl-piperidenmethanolderivater samt disses fremstilling

Info

Publication number
DK312386D0
DK312386D0 DK312386A DK312386A DK312386D0 DK 312386 D0 DK312386 D0 DK 312386D0 DK 312386 A DK312386 A DK 312386A DK 312386 A DK312386 A DK 312386A DK 312386 D0 DK312386 D0 DK 312386D0
Authority
DK
Denmark
Prior art keywords
piperidenmethanol
aralkyl
derivatives
preparation
piperidenmethanol derivatives
Prior art date
Application number
DK312386A
Other languages
English (en)
Other versions
DK174153B1 (da
DK312386A (da
Inventor
Albert A Carr
Norbert L Wiech
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK312386D0 publication Critical patent/DK312386D0/da
Publication of DK312386A publication Critical patent/DK312386A/da
Application granted granted Critical
Publication of DK174153B1 publication Critical patent/DK174153B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK198603123A 1985-07-02 1986-07-01 N-Aralkyl-piperidenmethanolderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende sådanne derivater DK174153B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75141985A 1985-07-02 1985-07-02
US75141985 1985-07-02

Publications (3)

Publication Number Publication Date
DK312386D0 true DK312386D0 (da) 1986-07-01
DK312386A DK312386A (da) 1987-01-03
DK174153B1 DK174153B1 (da) 2002-07-29

Family

ID=25021900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198603123A DK174153B1 (da) 1985-07-02 1986-07-01 N-Aralkyl-piperidenmethanolderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende sådanne derivater

Country Status (21)

Country Link
EP (1) EP0208235B1 (da)
JP (1) JPH0655720B2 (da)
KR (1) KR900001184B1 (da)
CN (1) CN1023895C (da)
AR (2) AR241904A1 (da)
AT (1) ATE49403T1 (da)
AU (1) AU590582B2 (da)
CA (1) CA1280421C (da)
DE (1) DE3668167D1 (da)
DK (1) DK174153B1 (da)
ES (1) ES2000299A6 (da)
FI (1) FI84474C (da)
GR (1) GR861699B (da)
HU (1) HU196058B (da)
IE (1) IE58460B1 (da)
IL (1) IL79266A (da)
NO (1) NO167384C (da)
NZ (1) NZ216689A (da)
PH (1) PH22141A (da)
PT (1) PT82890B (da)
ZA (1) ZA864772B (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
ZA888572B (en) * 1987-11-23 1989-08-30 Merrell Dow Pharma Treatment of fibromyalgia
JPH02138214A (ja) * 1987-12-10 1990-05-28 Merrell Dow Pharmaceut Inc 不安を治療する方法
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
DE3888340T2 (de) * 1988-01-21 1994-06-30 Merrell Dow Pharma Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ZA891901B (en) * 1988-03-17 1989-11-29 Merrell Dow Pharma Method for the treatment of the extrapyramidal side effects associated with neuroleptic therapy
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
AU636421B2 (en) * 1989-12-20 1993-04-29 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
JP2758050B2 (ja) * 1989-12-27 1998-05-25 株式会社トクヤマ 土質安定用薬液およびその注入工法
US6004980A (en) * 1990-06-01 1999-12-21 Merrell Pharmaceuticals, Inc. (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
HU213271B (en) * 1990-06-01 1997-04-28 Merrell Dow Pharma Process for producing (+)-alpha-(2,3-dimethoxi-phenyl)-1-[2-(4-fluoric-phenyl)-ethyl]-4-piperidine-methanole and pharmaceutical compositions containing the same
JPH07111050B2 (ja) * 1990-12-12 1995-11-29 株式会社親和テクノ セメントグラウトを用いた地盤注入工法
FR2672286B1 (fr) * 1991-01-31 1994-11-18 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
AU4659793A (en) * 1992-06-30 1994-01-24 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Anorectic epinephrine derivatives
FR2696741B1 (fr) * 1992-10-12 1994-11-25 Synthelabo Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique.
CA2108245A1 (en) * 1992-11-04 1994-05-05 Gary J. Grover Method for treating myocardial ischemia employing serotonin receptor antagonists
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
DE19681115D2 (de) * 1995-12-20 1999-11-25 Eckhart Pein Neue 1-Phenylalkyl/Alkylen-4-(.Alpha.-Hydroxydiphenylmethyl)-Piperidin Derivative und ihre Verwendung als Serotonin Antagonisten
US6028083A (en) * 1997-07-25 2000-02-22 Hoechst Marion Roussel, Inc. Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
US6713627B2 (en) 1998-03-13 2004-03-30 Aventis Pharmaceuticals Inc. Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
TWI249526B (en) * 1998-03-13 2006-02-21 Aventis Pharma Inc Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
SE9801516D0 (sv) 1998-04-30 1998-04-30 Maria Carlsson M100907/4-Piperidinemethanol derivatives for autism
DE19934432A1 (de) 1999-07-22 2001-02-01 Merck Patent Gmbh Indolderivate
DE19939756A1 (de) * 1999-08-21 2001-02-22 Merck Patent Gmbh Piperidinalkohole
US7345096B2 (en) 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7531543B2 (en) 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7524846B2 (en) 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7402698B2 (en) 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7419980B2 (en) 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
PT1691811E (pt) 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
DE102004010132A1 (de) 2004-02-27 2005-09-15 Merck Patent Gmbh Piperidinderivate
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US20060069124A1 (en) * 2004-09-07 2006-03-30 Rao P S Use of MDL-100,907 for treatment of allergic and eosinophil mediated diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3100775A (en) * 1959-04-01 1963-08-13 Searle & Co alpha-phenyl(pyridyl or piperidyl)alkyl esters of (chloro or lower alkoxy)-benzoic acids and congeners
ZA717147B (en) * 1970-11-27 1972-07-26 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)-4'-fluorobutyrophenone derivatives
SE7409245L (da) * 1973-07-19 1975-01-20 Robins Co Inc A H
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체

Also Published As

Publication number Publication date
FI84474C (fi) 1991-12-10
FI84474B (fi) 1991-08-30
KR900001184B1 (ko) 1990-02-27
EP0208235A1 (en) 1987-01-14
FI862801A0 (fi) 1986-07-01
EP0208235B1 (en) 1990-01-10
JPH0655720B2 (ja) 1994-07-27
GR861699B (en) 1986-10-31
NO862661D0 (no) 1986-07-01
AU590582B2 (en) 1989-11-09
NZ216689A (en) 1989-07-27
ATE49403T1 (de) 1990-01-15
PH22141A (en) 1988-06-01
FI862801A (fi) 1987-01-03
CN86104408A (zh) 1987-05-20
ES2000299A6 (es) 1988-02-16
HUT41387A (en) 1987-04-28
NO862661L (no) 1987-01-05
HU196058B (en) 1988-09-28
IE58460B1 (en) 1993-09-22
KR870001164A (ko) 1987-03-11
NO167384C (no) 1991-10-30
PT82890A (en) 1986-08-01
DK174153B1 (da) 2002-07-29
AR241904A1 (es) 1993-01-29
NO167384B (no) 1991-07-22
AR242184A1 (es) 1993-03-31
DE3668167D1 (de) 1990-02-15
DK312386A (da) 1987-01-03
CA1280421C (en) 1991-02-19
AU5931886A (en) 1987-01-08
IE861771L (en) 1987-01-02
JPS625955A (ja) 1987-01-12
IL79266A (en) 1990-04-29
PT82890B (pt) 1988-05-27
CN1023895C (zh) 1994-03-02
ZA864772B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
DK312386D0 (da) N-aralkyl-piperidenmethanolderivater samt disses fremstilling
DK289886D0 (da) Substituerede 3-phenyl-4-cyanopyrrol-derivater samt deres fremstilling og anvendelse
DK215687A (da) Radial keratotomikniv samt et med en saadan virken-de anlaeg
DK559985A (da) 13beta-milbemycinderivater samt deres fremstilling og anvendelse
DK164851C (da) N-phenylmethylenalkadienamider med analgetisk virkning samt farmaceutiske praeparater indeholdende samme
DK164852C (da) N-phenylmethylenalkanamider med analgetisk virkning samt farmaceutiske praeparater indeholdende samme
DK254488D0 (da) Azaindol- og indolizinderivater
DK29686A (da) 13beta-alkyl-milbemycinderivater samt deres fremstilling og anvendelse
DK139286A (da) Inden- og naphthalenderivater
DK470886D0 (da) Oxazol- og isoxazolderivater
DK162804C (da) Dinitroanilinpraeparat samt dettes fremstilling
DK537785D0 (da) Flavolignanderivater samt deres fremstilling og anvendelse
DK162186A (da) Aminoketonderivater samt laegemidler indeholdende saadanne derivater
DK157389D0 (da) Fluorphosphonatnucleotidderivater samt fremstilling heraf
DK236585A (da) Acylerede hexosederivater samt deres fremstilling og anvendelse
DK422685A (da) Benzazolderivater samt deres fremstilling og anvendelse
DK77286A (da) 1-0-acylerede hexosederivater samt deres fremstilling og anvendelse
FR2588259B1 (fr) Bis-acridiniques monopontes et bis-acridiniques bipontes
DK153285D0 (da) Benzodioxolderivater samt deres fremstilling og anvendelse
DK437986A (da) 1-amino-3-phenyl-propan-2-ol-derivater samt deres fremstilling og anvendelse
DK192188D0 (da) Chalkon-derivater samt anvendelsen heraf
DK117587D0 (da) 5-acyloxy-13beta-alkyl-milbemycin-derivater samt deres fremstilling og anvendelse
DK482385D0 (da) Fluorerede resorcinolethere samt deres fremstilling og anvendelse
DK471185D0 (da) 4-acylresorcinolethere samt deres fremstilling og anvendelse
DK108085D0 (da) Nye oxadiazolylimidazobenzodiazepinderivater samt fremgangsmaade tilfremstilling heraf

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired